France vs Maldives: Cause of death, by non-communicable diseases, female
France
79.3%
in 2021
Maldives
79.1%
in 2021
France rank
44th
Maldives rank
45th
Cause of death, by non-communicable diseases, female over time
- France
- Maldives
How they compare
France currently reports 79.3% against 79.1% in Maldives, a difference of 0.2%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was France ahead.
France ranks 44th and Maldives ranks 45th of 185 countries.
Across the 3 decades both report, France averaged higher in 1 and Maldives in 2.
Head to head by decade
| Decade | France | Maldives | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 85.9% | 74.0% | 11.9% | France |
| 2010s | 86.9% | 87.0% | 0.1% | Maldives |
| 2020s | 78.0% | 82.1% | 4.0% | Maldives |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, France or Maldives?
- France, at 79.3% against 79.1% in Maldives as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between France and Maldives?
- 0.2%, with France ahead.
- How many years of comparable data are there for France and Maldives?
- 6 years are reported by both, from 2000 to 2021.
- How do France and Maldives rank globally for cause of death, by non-communicable diseases, female?
- France ranks 44th and Maldives ranks 45th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.